Annual Accounts Receivable
$98.74 M
+$472.00 K+0.48%
December 31, 2024
Summary
- As of March 10, 2025, ACAD annual accounts receivable is $98.74 million, with the most recent change of +$472.00 thousand (+0.48%) on December 31, 2024.
- During the last 3 years, ACAD annual accounts receivable has risen by +$34.37 million (+53.40%).
- ACAD annual accounts receivable is now at all-time high.
Performance
ACAD Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$98.74 M
+$530.00 K+0.54%
December 31, 2024
Summary
- As of March 10, 2025, ACAD quarterly accounts receivable is $98.74 million, with the most recent change of +$530.00 thousand (+0.54%) on December 31, 2024.
- Over the past year, ACAD quarterly accounts receivable has stayed the same.
- ACAD quarterly accounts receivable is now -4.78% below its all-time high of $103.70 million, reached on June 30, 2024.
Performance
ACAD Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
ACAD Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +0.5% | 0.0% |
| 3 y3 years | +53.4% | +53.4% |
| 5 y5 years | +175.9% | +175.9% |
ACAD Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +58.8% | -4.8% | +77.2% |
| 5 y | 5-year | at high | +175.9% | -4.8% | +175.9% |
| alltime | all time | at high | -100.0% | -4.8% | -100.0% |
ACADIA Pharmaceuticals Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $98.74 M(+0.5%) | $98.74 M(+0.5%) |
| Sep 2024 | - | $98.21 M(-5.3%) |
| Jun 2024 | - | $103.70 M(+9.5%) |
| Mar 2024 | - | $94.70 M(-3.6%) |
| Dec 2023 | $98.27 M(+58.0%) | $98.27 M(+5.9%) |
| Sep 2023 | - | $92.80 M(+13.4%) |
| Jun 2023 | - | $81.85 M(+24.2%) |
| Mar 2023 | - | $65.92 M(+6.0%) |
| Dec 2022 | $62.20 M(-3.4%) | $62.20 M(+11.6%) |
| Sep 2022 | - | $55.73 M(-18.0%) |
| Jun 2022 | - | $67.95 M(+8.4%) |
| Mar 2022 | - | $62.71 M(-2.6%) |
| Dec 2021 | $64.37 M(+33.4%) | $64.37 M(+6.0%) |
| Sep 2021 | - | $60.70 M(+18.2%) |
| Jun 2021 | - | $51.37 M(-9.6%) |
| Mar 2021 | - | $56.83 M(+17.8%) |
| Dec 2020 | $48.25 M | $48.25 M(+4.1%) |
| Sep 2020 | - | $46.34 M(+5.8%) |
| Jun 2020 | - | $43.78 M(+5.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $41.64 M(+16.4%) |
| Dec 2019 | $35.78 M(+37.1%) | $35.78 M(+16.2%) |
| Sep 2019 | - | $30.80 M(-3.1%) |
| Jun 2019 | - | $31.78 M(+6.1%) |
| Mar 2019 | - | $29.96 M(+14.8%) |
| Dec 2018 | $26.09 M(+50.4%) | $26.09 M(+30.7%) |
| Sep 2018 | - | $19.96 M(-22.3%) |
| Jun 2018 | - | $25.70 M(+14.5%) |
| Mar 2018 | - | $22.45 M(+29.4%) |
| Dec 2017 | $17.34 M(+193.8%) | $17.34 M(+22.0%) |
| Sep 2017 | - | $14.22 M(+22.7%) |
| Jun 2017 | - | $11.59 M(+51.4%) |
| Mar 2017 | - | $7.66 M(+29.8%) |
| Dec 2016 | $5.90 M(>+9900.0%) | $5.90 M(+53.8%) |
| Sep 2016 | - | $3.84 M(+1210.2%) |
| Jun 2016 | - | $293.00 K(>+9900.0%) |
| Dec 2015 | $0.00 | $0.00(-100.0%) |
| Sep 2010 | - | $1.93 M(-34.0%) |
| Jun 2010 | - | $2.93 M |
FAQ
- What is ACADIA Pharmaceuticals annual accounts receivable?
- What is the all time high annual accounts receivable for ACADIA Pharmaceuticals?
- What is ACADIA Pharmaceuticals annual accounts receivable year-on-year change?
- What is ACADIA Pharmaceuticals quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for ACADIA Pharmaceuticals?
- What is ACADIA Pharmaceuticals quarterly accounts receivable year-on-year change?
What is ACADIA Pharmaceuticals annual accounts receivable?
The current annual accounts receivable of ACAD is $98.74 M
What is the all time high annual accounts receivable for ACADIA Pharmaceuticals?
ACADIA Pharmaceuticals all-time high annual accounts receivable is $98.74 M
What is ACADIA Pharmaceuticals annual accounts receivable year-on-year change?
Over the past year, ACAD annual accounts receivable has changed by +$472.00 K (+0.48%)
What is ACADIA Pharmaceuticals quarterly accounts receivable?
The current quarterly accounts receivable of ACAD is $98.74 M
What is the all time high quarterly accounts receivable for ACADIA Pharmaceuticals?
ACADIA Pharmaceuticals all-time high quarterly accounts receivable is $103.70 M
What is ACADIA Pharmaceuticals quarterly accounts receivable year-on-year change?
Over the past year, ACAD quarterly accounts receivable has changed by $0.00 (0.00%)